Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center.
Fabi A, Felici A, Metro G, Mirri A, Bria E, Telera S, Moscetti L, Russillo M, Lanzetta G, Mansueto G, Pace A, Maschio M, Vidiri A, Sperduti I, Cognetti F, Carapella CM. Fabi A, et al. Among authors: sperduti i. J Exp Clin Cancer Res. 2011 Jan 18;30(1):10. doi: 10.1186/1756-9966-30-10. J Exp Clin Cancer Res. 2011. PMID: 21244695 Free PMC article.
Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancer.
Di Cosimo S, Alimonti A, Ferretti G, Sperduti I, Carlini P, Papaldo P, Fabi A, Gelibter A, Ciccarese M, Giannarelli D, Mandalà M, Milella M, Ruggeri EM, Cognetti F. Di Cosimo S, et al. Among authors: sperduti i. Ann Oncol. 2004 Jul;15(7):1065-71. doi: 10.1093/annonc/mdh266. Ann Oncol. 2004. PMID: 15205200 Free article.
Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
Felici A, Carlini P, Ruggeri EM, Gamucci T, Pollera CF, De Marco S, Fariello AM, Moscetti L, Gelibter A, Adami E, Sperduti I, Cognetti F. Felici A, et al. Among authors: sperduti i. Cancer Chemother Pharmacol. 2006 Jan;57(1):59-64. doi: 10.1007/s00280-005-0032-5. Epub 2005 Nov 5. Cancer Chemother Pharmacol. 2006. PMID: 16001173 Clinical Trial.
Pegylated liposomal doxorubicin in combination with gemcitabine: a phase II study in anthracycline-naïve and anthracycline pretreated metastatic breast cancer patients.
Fabi A, Ferretti G, Papaldo P, Salesi N, Ciccarese M, Lorusso V, Carlini P, Carpino A, Mottolese M, Cianciulli AM, Giannarelli D, Sperduti I, Felici A, Cognetti F. Fabi A, et al. Among authors: sperduti i. Cancer Chemother Pharmacol. 2006 May;57(5):615-23. doi: 10.1007/s00280-005-0116-2. Epub 2005 Sep 15. Cancer Chemother Pharmacol. 2006. PMID: 16163541 Clinical Trial.
A phase II study on metastatic breast cancer patients treated with weekly vinorelbine with or without trastuzumab according to HER2 expression: changing the natural history of HER2-positive disease.
Papaldo P, Fabi A, Ferretti G, Mottolese M, Cianciulli AM, Di Cocco B, Pino MS, Carlini P, Di Cosimo S, Sacchi I, Sperduti I, Nardoni C, Cognetti F. Papaldo P, et al. Among authors: sperduti i. Ann Oncol. 2006 Apr;17(4):630-6. doi: 10.1093/annonc/mdj110. Epub 2006 Jan 12. Ann Oncol. 2006. PMID: 16410363 Free article. Clinical Trial.
Weekly paclitaxel, 5-fluorouracil and folinic acid with granulocyte colony-stimulating factor support in metastatic breast cancer patients: a phase II study.
Nistico C, Bria E, Agostara B, Barni S, Colella E, Frontini L, D'Ottavio AM, Cuppone F, Valenza R, Sperduti I, Izzo F, Terzoli E. Nistico C, et al. Among authors: sperduti i. Anticancer Drugs. 2006 Mar;17(3):345-51. doi: 10.1097/00001813-200603000-00014. Anticancer Drugs. 2006. PMID: 16520664 Clinical Trial.
408 results